This patent covers the use of various carbohydrate presenting molecules for increasing amount of stem cell homing to tissue where stem cell migration is desired. Specific molecules that attract the stem cells which are covered include asialoorosomucoid and orosomucoid.
This patent could be used to not only augment currented CD34 stem cell therapy efficacy but also in combination with stem cell mobilizing agents such as G-CSF.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.